2022 - Research.com Immunology in Germany Leader Award
His primary scientific interests are in Immunology, Arthritis, Internal medicine, Inflammation and Rheumatoid arthritis. Immunology is frequently linked to Bone resorption in his study. His research integrates issues of Cortical bone, Bone marrow, Pathology and Osteoclast in his study of Arthritis.
The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Surgery. His Inflammation study combines topics from a wide range of disciplines, such as Phagocytosis, Immune system and Pathogenesis. His Rheumatoid arthritis research includes elements of Gastroenterology, Connective tissue disease and Disease.
His main research concerns Internal medicine, Immunology, Rheumatoid arthritis, Arthritis and Inflammation. His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology. His research in Rheumatoid arthritis intersects with topics in Quantitative computed tomography, Disease, Pathology, Connective tissue disease and Physical therapy.
He interconnects Surgery, Cancer research and Cartilage in the investigation of issues within Arthritis. His Inflammation research integrates issues from Tumor necrosis factor alpha and Osteoclast. His work focuses on many connections between Osteoclast and other disciplines, such as Bone remodeling, that overlap with his field of interest in Bone resorption.
Georg Schett spends much of his time researching Internal medicine, Rheumatoid arthritis, Arthritis, Immunology and Psoriatic arthritis. The Rheumatology and Disease research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. Georg Schett studies Rheumatoid arthritis, focusing on Rheumatoid factor in particular.
His studies deal with areas such as Tumor necrosis factor alpha, Endocrinology, Bone remodeling and RANKL as well as Arthritis. Immune system, Inflammation, Autoimmunity, Cytokine and Autoantibody are among the areas of Immunology where he concentrates his study. His work in Inflammation tackles topics such as Cell biology which are related to areas like Osteoclast, Chromatin and Fibrosis.
Georg Schett mostly deals with Inflammation, Immunology, Arthritis, Internal medicine and Rheumatoid arthritis. His studies in Inflammation integrate themes in fields like Osteoclast, Innate lymphoid cell, Cytokine and Cell biology. His biological study spans a wide range of topics, including Disease and Eosinophilic.
His work carried out in the field of Arthritis brings together such families of science as Tumor necrosis factor alpha, Autoimmune disease, Macrophage and Peripheral blood mononuclear cell. The various areas that Georg Schett examines in his Internal medicine study include Gastroenterology and Placebo. His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Eosinophil, Clinical trial, Interleukin 6, Autoantibody and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The pathogenesis of rheumatoid arthritis.
Iain B. McInnes;Georg Schett.
The New England Journal of Medicine (2011)
Cytokines in the pathogenesis of rheumatoid arthritis
Iain B. McInnes;Georg Schett.
Nature Reviews Immunology (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra;Marina Stolina;Karin Polzer;Jochen Zwerina.
Nature Medicine (2007)
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
L Gossec;J S Smolen;S Ramiro;M de Wit.
Annals of the Rheumatic Diseases (2016)
Osteoclasts are essential for TNF-α–mediated joint destruction
Kurt Redlich;Silvia Hayer;Romeo Ricci;Jean-Pierre David.
Journal of Clinical Investigation (2002)
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
Ulrike Harre;Dan Georgess;Holger Bang;Aline Bozec.
Journal of Clinical Investigation (2012)
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
Stefan Kiechl;Georg Schett;Gregor Wenning;Kurt Redlich.
Trial of Tocilizumab in Giant-Cell Arteritis.
John H Stone;Katie Tuckwell;Sophie Dimonaco;Micki Klearman.
The New England Journal of Medicine (2017)
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Georg Schett;Ellen M. Gravallese.
Nature Reviews Rheumatology (2012)
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
Alfiya Akhmetshina;Katrin Palumbo;Clara Dees;Christina Bergmann.
Nature Communications (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: